Logo image of GEHC

GE HEALTHCARE TECHNOLOGY (GEHC) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:GEHC - US36266G1076 - Common Stock

76.45 USD
+1.7 (+2.27%)
Last: 11/21/2025, 8:00:01 PM
76.47 USD
+0.02 (+0.03%)
After Hours: 11/21/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
GEHC revenue by date.GEHC revenue by date.
18.341B
4.30%
19.552B
6.60%
19.672B
0.61%
20.932B
6.41%
21.862B
4.44%
22.849B
4.51%
23.604B
3.30%
24.279B
2.86%
24.388B
0.45%
EBITDA
YoY % growth
GEHC ebitda by date.GEHC ebitda by date.
3.155B
-7.75%
3.045B
-3.49%
3.205B
5.25%
3.687B
15.04%
3.959B
7.38%
4.211B
6.37%
4.673B
10.97%
4.91B
5.07%
N/A
EBIT
YoY % growth
GEHC ebit by date.GEHC ebit by date.
2.522B
-9.77%
2.435B
-3.45%
2.625B
7.80%
3.101B
18.13%
3.369B
8.64%
3.713B
10.21%
4.056B
9.24%
N/AN/A
Operating Margin
GEHC operating margin by date.GEHC operating margin by date.
13.75%12.45%13.34%14.81%15.41%16.25%17.18%N/AN/A
EPS
YoY % growth
GEHC eps by date.GEHC eps by date.
N/A3.94
10.02%
4.49
13.96%
4.64
3.36%
5.04
8.63%
5.63
11.73%
6.12
8.60%
6.46
5.54%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
1.42
-1.82%
1.03
2.25%
1.19
12.08%
1.28
19.25%
1.51
6.04%
1.18
14.57%
1.24
4.74%
1.34
4.72%
1.77
17.57%
Revenue
Q2Q % growth
5.723B
7.60%
5.105B
6.87%
5.333B
6.51%
5.436B
5.70%
5.92B
3.44%
5.475B
7.25%
5.586B
4.74%
5.653B
3.99%
6.282B
6.11%
EBITDA
Q2Q % growth
1.085B
-21.43%
831.08M
8.64%
942.45M
0.47%
1B
-7.83%
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
945M
17.98%
692.02M
10.02%
789.12M
20.66%
845M
29.40%
988.24M
4.58%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
1.07
-6.14%
1.070.00-0.16%
Q2 2025
Q2Q % growth
1.06
6.00%
0.940.1213.24%
Q1 2025
Q2Q % growth
1.01
12.22%
0.930.088.42%
Q4 2024
Q2Q % growth
1.45
22.88%
1.290.1612.49%
Q3 2024
Q2Q % growth
1.14
15.15%
1.070.076.17%
Q2 2024
Q2Q % growth
1.00
8.70%
1.000.000.18%
Q1 2024
Q2Q % growth
0.90
5.88%
0.92-0.02-2.68%
Q4 2023
Q2Q % growth
1.18
-9.92%
1.090.098.08%
Q3 2023
Q2Q % growth
0.99 0.910.088.23%
Q2 2023
Q2Q % growth
0.92 0.890.033.67%
Q1 2023
Q2Q % growth
0.85 0.810.045.15%
GEHC Yearly EPS VS EstimatesGEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
5.143B
5.76%
5.182B-39M-0.75%
Q2 2025
Q2Q % growth
5.007B
3.47%
5.062B-55M-1.09%
Q1 2025
Q2Q % growth
4.777B
2.73%
4.757B20M0.42%
Q4 2024
Q2Q % growth
5.319B
2.17%
5.437B-118M-2.17%
Q3 2024
Q2Q % growth
4.863B
0.85%
4.966B-103M-2.07%
Q2 2024
Q2Q % growth
4.839B
0.46%
4.97B-131M-2.64%
Q1 2024
Q2Q % growth
4.65B
-1.21%
4.897B-247M-5.04%
Q4 2023
Q2Q % growth
5.206B
5.43%
5.193B13M0.25%
Q3 2023
Q2Q % growth
4.822B
5.38%
4.901B-79M-1.61%
Q2 2023
Q2Q % growth
4.817B
-45.43%
4.89B-73M-1.49%
Q1 2023
Q2Q % growth
4.707B 4.727B-20M-0.42%
Q4 2022
Q2Q % growth
4.938B
7.61%
%
Q3 2022
Q2Q % growth
4.576B
6.32%
%
Q2 2022
Q2Q % growth
8.827B
1.55%
%
GEHC Yearly Revenue VS EstimatesGEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.47% 0.22% 0.51% 0.63%
Revenue-0.12% -0.14% 0.36% 0.3%